Clozapine's secret weapon? study probes inflammation link in tough schizophrenia cases
NCT ID NCT05741502
First seen Feb 27, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This study aimed to understand why clozapine works better than other antipsychotics for treatment-resistant schizophrenia. Researchers planned to compare levels of inflammatory markers like interleukin-6 in people taking clozapine versus those on other antipsychotics. Only 5 people enrolled before the study was terminated, so no conclusions could be drawn.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ohio State University Harding Hospital
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.